HBP.TO HELIX BIOPHARMA CORP
$1.45▼ -4.61%
Healthcare
Other
Volume 3.8K
Avg Volume (10D) 2.6K
Key Metrics & Fundamentals
Market Cap
$110.75M
P/E Ratio
–
Div Yield
–%
52W Range
1.10 - 5.40
% vs 50 MA
-11.44%
% vs 200 MA
-21.45%
RSI-14
33.9
MACD Histogram
-0.0600
Beta (1Y vs SPY)
0.10
Free Cash Flow
-$880,000
Gross Rev
$0
Gross Profit
$0
EBITDA
-$689,000
COGS
–
Operating Exp
$690,000
Operating Income
-$690,000
EBIT
-$690,000
Pretax Income
-$671,000
Net Income
-$671,000
EPS (Diluted)
-0.01
Price & Volume History
Loading chart…
Recent News
Helix BioPharma Corp. Appoints Markus Loeffler, MD, MBA, as Chief Medical Officer to Support Next Phase of Clinical Development
NewMediaWire · Aug 17, 2026 9:15 PM
Helix Biopharma Corp. Announces Board Composition Changes
NewMediaWire · Aug 14, 2026 9:15 PM
Helix BioPharma Corp. Strengthens Executive Leadership to Support U.S. Listing Strategy and Next Phase of Clinical Development
NewMediaWire · Jun 30, 2026 9:15 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See HBP.TO's money flow as a full page
Social Sentiment
No Reddit posts found for HBP.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.